IN8bio (STU:6JH0) Non Operating Income : €-0.96 Mil (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is IN8bio Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. IN8bio's Non Operating Income for the three months ended in Mar. 2025 was €0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.96 Mil.

IN8bio Non Operating Income Historical Data

The historical data trend for IN8bio's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IN8bio Non Operating Income Chart

IN8bio Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Non Operating Income

Get a 7-Day Free Trial

0.30

-1.02

IN8bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Non Operating Income	Get a 7-Day Free Trial															-	-	-0.96	-	-

IN8bio Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.96 Mil.

IN8bio Non Operating Income Related Terms

Thank you for viewing the detailed overview of IN8bio's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

IN8bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IN8bio Inc (STU:6JH0) » Definitions » Non Operating Income

Comparable Companies

Traded in Other Exchanges

INAB:USA 6JH:Germany

Address

350 5th Avenue, Suite 5330, New York, NY, USA, 10118

Website

https://www.in8bio.com

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

IN8bio Headlines

No Headlines